Creatine and Creatinine Metabolism - Physiological Reviews

1194 MARKUS WYSS AND RIMA KADDURAH-DAOUK Volume 80
395. IENAGA K, NAKAMURA K, NAKA F, AND GOTO T. The metabolism
of 1-methylhydantoin via 5-hydroxy-1-methylhydantoin in
mammals. Biochim Biophys Acta 967: 441–443, 1988.
396. IENAGA K, NAKAMURA K, YAMAKAWA M, TOYOMAKI Y, MAT-
SUURA H, YOKOZAWA T, OURA H, AND NAKANO K. The use of
13 C-labelling to prove that creatinine is oxidized by mammals into
creatol and 5-hydroxy-1-methylhydantoin. J Chem Soc Chem
Commun 509–510, 1991.
397. IM YS, CHIANG PK, AND CANTONI GL. Guanidoacetate methyltransferase.
Purification and molecular properties. J Biol Chem
254: 11047–11050, 1979.
398. INANA G, HOTTA Y, ZINTZ C, CHAMBERS C, KENNAWAY NG,
WELEBER RG, NAKAJIMA A, AND SHIONO T. Molecular basis of
ornithine aminotransferase defect in gyrate atrophy. Prog Clin
Biol Res 362: 191–219, 1991.
399. INGROSSO D, FOWLER AV, BLEIBAUM J, AND CLARKE S. Sequence
of the D-aspartyl/L-isoaspartyl protein methyltransferase
from human erythrocytes. Common sequence motifs for protein,
DNA, RNA, and small molecule S-adenosylmethionine-dependent
methyltransferases. J Biol Chem 264: 20131–20139, 1989.
400. INGWALL JS. The hypertrophied myocardium accumulates the
MB-creatine kinase isozyme. Eur Heart J 5 Suppl F: 129–139,
1984.
401. INGWALL JS. Is cardiac failure a consequence of decreased energy
reserve? Circulation 87 Suppl VII: VII-58–VII-62, 1993.
402. INGWALL JS. Whole-organ enzymology of the creatine kinase
system in heart. Biochem Soc Trans 19: 1006–1010, 1991.
403. INGWALL JS, ATKINSON DE, CLARKE K, AND FETTERS JK.
Energetic correlates of cardiac failure: changes in the creatine
kinase system in the failing myocardium. Eur Heart J 11 Suppl B:
108–115, 1990.
404. INGWALL JS AND FOSSEL ET. Changes in the creatine kinase
system in the hypertrophied myocardium of the dog and rat. In:
Perspectives in Cardiovascular Research, edited by N. R. Alpert.
New York: Raven, 1983, p. 601–617.
405. INGWALL JS, KRAMER MF, FIFER MA, LORELL BH, SHEMIN R,
GROSSMAN W, AND ALLEN PD. The creatine kinase system in
normal and diseased human myocardium. N Engl J Med 313:
1050–1054, 1985.
406. INGWALL JS AND WILDENTHAL K. Role of creatine in the regulation
of cardiac protein synthesis. J Cell Biol 68: 159–163, 1976.
407. INOUYE Y, MATSUDA Y, NAID T, ARAI S, HASHIMOTO Y,
ASANO K, OZAKI M, AND NAKAMURA S. Purification and characterization
of creatinine amidohydrolase of Alcaligenes origin.
Chem Pharm Bull 34: 269–274, 1986.
408. IPATA PL, MARMOCCHI F, MAGNI G, FELICIOLI R, AND POLI-
DORO G. Baker’s yeast cytosine deaminase. Some enzymic properties
and allosteric inhibition by nucleosides and nucleotides.
Biochemistry 10: 4270–4276, 1971.
409. ISBRANDT D AND VON FIGURA K. Cloning and sequence analysis
of human guanidinoacetate N-methyltransferase cDNA. Biochim
Biophys Acta 1264: 265–267, 1995.
410. ISHIKAWA F, TAKAKU F, NAGAO M, OCHIAI M, HAYASHI K,
TAKAYAMA S, AND SUGIMURA T. Activated oncogenes in a rat
hepatocellular carcinoma induced by 2-amino-3-methyl-imidazo[4,5-f]quinoline.
Jpn J Cancer Res 76: 425–428, 1985.
411. ISHIKAWA Y, SAFFITZ JE, MEALMAN TL, GRACE AM, AND ROB-
ERTS R. Reversible myocardial ischemic injury is not associated
with increased creatine kinase activity in plasma. Clin Chem 43:
467–475, 1997.
412. ISHIZAKI M, KITAMURA H, TAGUMA Y, AOYAGI K, AND NARITA
M. Urinary excretion rate of guanidinoacetic acid as a sensitive
indicator of early-stage nephropathy. In: Guanidino Compounds
in Biology and Medicine, edited by P. P. De Deyn, B. Marescau,
V. Stalon, and I. A. Qureshi. London: Libbey, 1992, p. 275–280.
413. ITO N, HASEGAWA R, IMAIDA K, TAMANO S, HAGIWARA A,
HIROSE M, AND SHIRAI T. Carcinogenicity of 2-amino-1-methyl-
6-phenylimidazo[4,5-b]pyridine (PhIP) in the rat. Mutat Res 376:
107–114, 1997.
414. IYENGAR MR, COLEMAN DW, AND BUTLER TM. Phosphocreatinine,
a high-energy phosphate in muscle, spontaneously forms
phosphocreatine and creatinine under physiological conditions.
J Biol Chem 260: 7562–7567, 1985.
415. IYER GS, KRAHE R, GOODWIN LA, DOGGETT NA, SICILIANO
MJ, FUNANAGE VL, AND PROUJANSKY R. Identification of a
testis-expressed creatine transporter gene at 16p11.2 and confirmation
of the X-linked locus to Xq28. Genomics 34: 143–146, 1996.
416. IZAWA S, HARADA N, WATANABE T, KOTOKAWA N,
YAMAMOTO A, HAYATSU H, AND ARIMOTO-KOBAYASHI S. Inhibitory
effects of food-coloring agents derived from Monascus on
the mutagenicity of heterocyclic amines. J Agric Food Chem 45:
3980–3984, 1997.
417. JACKSON LS AND HARGRAVES WA. Effects of time and temperature
on the formation of MeIQ x and DiMeIQ x in a model system
containing threonine, glucose, and creatine. J Agric Food Chem
43: 1678–1684, 1995.
418. JACOBS I, BLEUE S, AND GOODMAN J. Creatine ingestion increases
anaerobic capacity and maximum accumulated oxygen
deficit. Can J Appl Physiol 22: 231–243, 1997.
419. JACOBSTEIN MD, GERKEN TA, BHAT AM, AND CARLIER PG.
Myocardial protection during ischemia by prior feeding with the
creatine analog cyclocreatine. J Am Coll Cardiol 14: 246–251,
1989.
420. JACOBUS WE, BITTL JA, AND WEISFELDT ML. Loss of mitochondrial
creatine kinase in vitro and in vivo: a sensitive index of
ischemic cellular and functional damage. In: Heart Creatine Kinase,
edited by W. E. Jacobus and J. S. Ingwall. Baltimore, MD:
Williams & Wilkins, 1980, p. 155–175.
421. JACOBUS WE AND SAKS VA. Creatine kinase of heart mitochondria:
changes in its kinetic properties induced by coupling to
oxidative phosphorylation. Arch Biochem Biophys 219: 167–178,
1982.
422. JAFFE M. Ueber den Niederschlag, welchen Pikrinsäure in normalem
Harn erzeugt und über eine neue Reaction des Kreatinins.
Hoppe-Seyler’s Z Physiol Chem 10: 391–400, 1886.
423. JÄGERSTAD M, LASER REUTERSWÄRD A, ÖSTE R, AND DAHL-
QVIST A. Creatinine and Maillard reaction products as precursors
of mutagenic compounds formed in fried beef. In: The Maillard
Reaction in Foods and Nutrition, edited by G. R. Waller and M. S.
Feather. Washington, DC: Am. Chem. Soc., 1983, p. 507–519.
424. JÄGERSTAD M, SKOG K, GRIVAS S, AND OLSSON K. Formation
of heterocyclic amines using model systems. Mutat Res 259: 219–
233, 1991.
425. JANSSON E, SYLVÉN C, HENZE A, AND KAIJSER L. Myocardial
enzyme activities in patients with mitral regurgitation or mitral
stenosis. Cardiovasc Res 21: 202–207, 1987.
426. JAVIERRE C, LIZARRAGA MA, VENTURA JL, GARRIDO E, AND
SEGURA R. Creatine supplementation does not improve physical
performance in a 150 m race. J Physiol Biochem 53: 343–348,
1997.
427. JENNE DE, OLSEN AS, AND ZIMMER M. The human guanidinoacetate
methyltransferase (GAMT) gene maps to a syntenic region
on 19p13.3, homologous to band C of mouse chromosome 10, but
GAMT is not mutated in jittery mice. Biochem Biophys Res Commun
238: 723–727, 1997.
428. JENNER P AND OLANOW CW. Understanding cell death in Parkinson’s
disease. Ann Neurol 44 Suppl 1: S72–S84, 1998.
429. JENNINGS RB, REIMER KA, HILL ML, AND MAYER SE. Total
ischemia in dog hearts, in vitro. 1. Comparison of high energy
phosphate production, utilization, and depletion, and of adenine
nucleotide catabolism in total ischemia in vitro vs severe ischemia
in vivo. Circ Res 49: 892–900, 1981.
430. JENNINGS RB AND STEENBERGEN C. Nucleotide metabolism
and cellular damage in myocardial ischemia. Annu Rev Physiol
47: 727–749, 1985.
431. JERNBERG-WIKLUND H, PETTERSSON M, AND NILSSON K. Recombinant
interferon-� inhibits the growth of IL-6-dependent human
multiple myeloma cell lines in vitro. Eur J Haematol 46:
231–239, 1991.
432. JIAO Y, OKUMIYA T, SAIBARA T, TSUBOSAKI E, MATSUMURA
H, PARK K, SUGIMOTO K, KAGEOKA T, AND SASAKI M. An
enzymatic assay for erythrocyte creatine as an index of the erythrocyte
life time. Clin Biochem 31: 59–65, 1998.
433. JINNAI D, MORI A, MUKAWA J, OHKUSU H, HOSOTANI M,
MIZUNO A, AND TYE LC. Biochemical and physiological studies